FI963509A - Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina - Google Patents

Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina Download PDF

Info

Publication number
FI963509A
FI963509A FI963509A FI963509A FI963509A FI 963509 A FI963509 A FI 963509A FI 963509 A FI963509 A FI 963509A FI 963509 A FI963509 A FI 963509A FI 963509 A FI963509 A FI 963509A
Authority
FI
Finland
Prior art keywords
lipoxygenase inhibitors
isoxazoline compounds
isoxazoline
compounds
lipoxygenase
Prior art date
Application number
FI963509A
Other languages
English (en)
Swedish (sv)
Other versions
FI963509A0 (fi
Inventor
Victoria L Cohan
Edward F Kleinman
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI963509A0 publication Critical patent/FI963509A0/fi
Publication of FI963509A publication Critical patent/FI963509A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI963509A 1994-03-09 1996-09-06 Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina FI963509A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20876894A 1994-03-09 1994-03-09
PCT/IB1995/000041 WO1995024192A1 (en) 1994-03-09 1995-01-19 Isoxazoline compounds as 5-lipoxygenase inhibitors

Publications (2)

Publication Number Publication Date
FI963509A0 FI963509A0 (fi) 1996-09-06
FI963509A true FI963509A (fi) 1996-09-06

Family

ID=22775981

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963509A FI963509A (fi) 1994-03-09 1996-09-06 Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina

Country Status (11)

Country Link
US (1) US5696141A (fi)
EP (1) EP0749307A1 (fi)
JP (1) JPH09505081A (fi)
AU (1) AU1326795A (fi)
CA (1) CA2184914C (fi)
FI (1) FI963509A (fi)
IL (1) IL112849A (fi)
MX (1) MX9603943A (fi)
MY (1) MY112586A (fi)
WO (1) WO1995024192A1 (fi)
ZA (1) ZA951911B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010241567B2 (en) 2009-04-29 2013-10-31 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62103070A (ja) * 1985-10-29 1987-05-13 Mitsui Toatsu Chem Inc イソオキサゾリン誘導体および植物生長調節剤
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
IL92915A0 (en) * 1989-01-05 1990-09-17 Ciba Geigy Ag Certain pyrrolylphenyl-substituted hydroxamic acid derivatives
CA2017383A1 (en) * 1989-06-08 1990-12-08 Raymond R. Martodam Use of vanilloids for the treatment of respiratory diseases or disorders
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
DE3939010A1 (de) * 1989-11-25 1991-05-29 Hoechst Ag Isoxazoline, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschuetzende mittel
JP2787602B2 (ja) * 1990-01-24 1998-08-20 大鵬薬品工業株式会社 イソキサゾリン誘導体
US5234937A (en) * 1990-03-27 1993-08-10 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxphenyl oxazolyl methanones and related compounds as antiinflammatory agents
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
IE913855A1 (en) * 1990-11-06 1992-05-22 Smithkline Beecham Corp Imidazolidinone compounds
PT100441A (pt) * 1991-05-02 1993-09-30 Smithkline Beecham Corp Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
GB9215921D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Anti-inflammatory compounds
US5288397A (en) * 1992-09-18 1994-02-22 Mobil Oil Corporation Baffled FCC regeneration process and apparatus
WO1994018158A1 (en) * 1993-02-15 1994-08-18 Pfizer Inc. Spiroalkylhydroxyureas for use as lipoxygenase inhibitors

Also Published As

Publication number Publication date
MY112586A (en) 2001-07-31
US5696141A (en) 1997-12-09
MX9603943A (es) 1997-04-30
FI963509A0 (fi) 1996-09-06
IL112849A0 (en) 1995-06-29
ZA951911B (en) 1996-09-09
WO1995024192A1 (en) 1995-09-14
EP0749307A1 (en) 1996-12-27
CA2184914C (en) 2000-09-19
JPH09505081A (ja) 1997-05-20
CA2184914A1 (en) 1995-09-14
AU1326795A (en) 1995-09-25
IL112849A (en) 1999-04-11

Similar Documents

Publication Publication Date Title
DK0818448T3 (da) Cycloalkanopyridiner som CETP-inhibitorer
FI944804A (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
NO992821D0 (no) Ketobenzamider som calpain-inhibitorer
FI962800A0 (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
DK0777671T3 (da) Spiro-azabicykliske forbindelser
FI963597A (fi) Isoprenyylitransferaasi-inhibiittoreita
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO972743D0 (no) Fremgangsmåte for oppnåelse av mikroorganismer som nedbryter organiske forbindelser
EE9800430A (et) Uued ühendid
TR199501665A2 (tr) Temizleme bilesimleri.
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
DK0934264T3 (da) Pyrrolidinyl- og pyrrolinylethylaminforbindelser som kappa-agonister
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
NO972257D0 (no) 18-nor-vitamin D-forbindelser
IS4932A (is) Ný efnasambönd
FI963509A (fi) Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina
FI960371A0 (fi) Tiatsolijohdannaisia lipoksigenaasi-inhibiittoreina
FI944788A0 (fi) Skidstav som foeljer roerelse
SE9402170D0 (sv) New compounds
SE9402813D0 (sv) New compounds
SE9402838D0 (sv) New compounds
SE9403728D0 (sv) New compounds
ITMI951259A0 (it) Composti chimici